The wealthy founder of a drug company is heading to trial on allegations that he led a scheme to bribe doctors into prescribing a highly addictive fentanyl spray.
Star Tribune Staff, Minneapolis Star Tribune: Business
Mon, 01/28/2019 - 4:10am
The wealthy founder of a drug company is heading to trial on allegations that he led a scheme to bribe doctors into prescribing a highly addictive fentanyl spray.